000908819 001__ 908819
000908819 005__ 20230123110635.0
000908819 0247_ $$2doi$$a10.1128/jvi.00685-22
000908819 0247_ $$2ISSN$$a0022-538X
000908819 0247_ $$2ISSN$$a1070-6321
000908819 0247_ $$2ISSN$$a1098-5514
000908819 0247_ $$2Handle$$a2128/31619
000908819 0247_ $$2pmid$$a35674432
000908819 0247_ $$2WOS$$aWOS:000810989000003
000908819 037__ $$aFZJ-2022-02856
000908819 082__ $$a610
000908819 1001_ $$0P:(DE-Juel1)165152$$aSevenich, Marc$$b0$$ufzj
000908819 245__ $$aA So-Far Overlooked Secondary Conformation State in the Binding Mode of SARS-CoV-2 Spike Protein to Human ACE2 and Its Conversion Rate Are Crucial for Estimating Infectivity Efficacy of the Underlying Virus Variant
000908819 260__ $$aBaltimore, Md.$$bSoc.$$c2022
000908819 3367_ $$2DRIVER$$aarticle
000908819 3367_ $$2DataCite$$aOutput Types/Journal article
000908819 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1661148462_5165
000908819 3367_ $$2BibTeX$$aARTICLE
000908819 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000908819 3367_ $$00$$2EndNote$$aJournal Article
000908819 520__ $$aSince its outbreak in 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread with high transmission efficiency across the world, putting health care as well as economic systems under pressure. During the course of the pandemic, the originally identified SARS-CoV-2 variant has been multiple times replaced by various mutant versions, which showed enhanced fitness due to increased infection and transmission rates. In order to find an explanation for why SARS-CoV-2 and its emerging mutated versions showed enhanced transmission efficiency compared with SARS-CoV (2002), an enhanced binding affinity of the spike protein to human angiotensin converting enzyme 2 (hACE2) has been proposed by crystal structure analysis and was identified in cell culture models. Kinetic analysis of the interaction of various spike protein constructs with hACE2 was considered to be best described by a Langmuir-based 1:1 stoichiometric interaction. However, we demonstrate in this report that the SARS-CoV-2 spike protein interaction with hACE2 is best described by a two-step interaction, which is defined by an initial binding event followed by a slower secondary rate transition that enhances the stability of the complex by a factor of ~190 (primary versus secondary state) with an overall equilibrium dissociation constant (KD) of 0.20 nM. In addition, we show that the secondary rate transition is not only present in SARS-CoV-2 wild type (“wt”; Wuhan strain) but also found in the B.1.1.7 variant, where its transition rate is 5-fold increased.IMPORTANCE The current SARS-CoV-2 pandemic is characterized by the high infectivity of SARS-CoV-2 and its derived variants of concern (VOCs). It has been widely assumed that the reason for its increased cell entry compared with SARS-CoV (2002) is due to alterations in the viral spike protein, where single amino acid residue substitutions can increase affinity for hACE2. So far, the interaction of a single unit of the CoV-2 spike protein has been described using the 1:1 Langmuir interaction kinetic. However, we demonstrate here that there is a secondary state binding step that may be essential for novel VOCs in order to further increase their infectivity. These findings are important for quantitatively understanding the infection process of SARS-CoV-2 and characterization of emerging SARS-CoV-2 variants of spike proteins. Thus, they provide a tool for predicting the potential infectivity of the respective viral variants based on secondary rate transition and secondary complex stability.
000908819 536__ $$0G:(DE-HGF)POF4-5244$$a5244 - Information Processing in Neuronal Networks (POF4-524)$$cPOF4-524$$fPOF IV$$x0
000908819 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
000908819 7001_ $$0P:(DE-HGF)0$$avan den Heuvel, Joop$$b1
000908819 7001_ $$0P:(DE-Juel1)171922$$aGering, Ian$$b2$$ufzj
000908819 7001_ $$0P:(DE-Juel1)132012$$aMohrlüder, Jeannine$$b3$$ufzj
000908819 7001_ $$0P:(DE-Juel1)132029$$aWillbold, Dieter$$b4$$eCorresponding author
000908819 773__ $$0PERI:(DE-600)1495529-5$$a10.1128/jvi.00685-22$$gVol. 96, no. 13, p. e00685-22$$n13$$pe00685-22$$tJournal of virology$$v96$$x0022-538X$$y2022
000908819 8564_ $$uhttps://juser.fz-juelich.de/record/908819/files/Invoice_94313278.pdf
000908819 8564_ $$uhttps://juser.fz-juelich.de/record/908819/files/jvi.00685-22.pdf$$yOpenAccess
000908819 8767_ $$894313278$$92022-07-25$$a1200183076$$d2022-08-01$$eHybrid-OA$$jZahlung erfolgt$$zUSD 2600,-
000908819 909CO $$ooai:juser.fz-juelich.de:908819$$pdnbdelivery$$popenCost$$pVDB$$pdriver$$pOpenAPC$$popen_access$$popenaire
000908819 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)165152$$aForschungszentrum Jülich$$b0$$kFZJ
000908819 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)171922$$aForschungszentrum Jülich$$b2$$kFZJ
000908819 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)132012$$aForschungszentrum Jülich$$b3$$kFZJ
000908819 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)132029$$aForschungszentrum Jülich$$b4$$kFZJ
000908819 9131_ $$0G:(DE-HGF)POF4-524$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5244$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vMolecular and Cellular Information Processing$$x0
000908819 9141_ $$y2022
000908819 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000908819 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-01-28
000908819 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-01-28
000908819 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-01-28
000908819 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000908819 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ VIROL : 2021$$d2022-11-17
000908819 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-17
000908819 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-17
000908819 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2022-11-17
000908819 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2022-11-17
000908819 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-17
000908819 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-17
000908819 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2022-11-17
000908819 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2022-11-17
000908819 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bJ VIROL : 2021$$d2022-11-17
000908819 9201_ $$0I:(DE-Juel1)IBI-7-20200312$$kIBI-7$$lStrukturbiochemie$$x0
000908819 980__ $$ajournal
000908819 980__ $$aVDB
000908819 980__ $$aUNRESTRICTED
000908819 980__ $$aI:(DE-Juel1)IBI-7-20200312
000908819 980__ $$aAPC
000908819 9801_ $$aAPC
000908819 9801_ $$aFullTexts